Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars

Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars

In Episode 28, Miroslav Gasparek, Sensible; Lizzy Lawrence, STAT; and Joe Lewis, Deloitte, go behind the headlines.

Inside the FDA Dysfunction

Key Takeaways The Wall Street Journal board calls out FDA dysfunction under Health Secretary Robert F. Kennedy Jr. George Tidmarsh, head of the FDA’s drug center, resigned after a LinkedIn post led to a lawsuit. Critics say shifting standards and mixed messages slow down life-saving drugs. The agency’s credibility and patient health could suffer if issues persist. The Food and Drug Administration faces sharp criticism from a major newspaper boa…